ArticleTurkish journal of surgery2025

Trastuzumab significantly improves survival in resectable HER-2 positive gastric cancer: A retrospective study.

Olgun Erdem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.